BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 23331180)

  • 1. Interleukin-17 enhances the production of interferon-γ and tumour necrosis factor-α by bone marrow T lymphocytes from patients with lower risk myelodysplastic syndromes.
    Zhang Z; Li X; Guo J; Xu F; He Q; Zhao Y; Yang Y; Gu S; Zhang Y; Wu L; Chang C
    Eur J Haematol; 2013 May; 90(5):375-84. PubMed ID: 23331180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-27 enhances the production of tumour necrosis factor-α and interferon-γ by bone marrow T lymphocytes in aplastic anaemia.
    Li J; Zhao Q; Xing W; Feng J; Wu H; Li H; Ge M; Tian K; Li X; Zhou J; Liu B; Zhang L; Zheng Y; Han ZC
    Br J Haematol; 2011 Jun; 153(6):764-72. PubMed ID: 21506940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th22 cells as well as Th17 cells expand differentially in patients with early-stage and late-stage myelodysplastic syndrome.
    Shao LL; Zhang L; Hou Y; Yu S; Liu XG; Huang XY; Sun YX; Tian T; He N; Ma DX; Peng J; Hou M
    PLoS One; 2012; 7(12):e51339. PubMed ID: 23236476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
    Wu LY; Li X; Chang CK; Ying SX; Pu Q
    Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on negative regulatory factors in bone marrow mononuclear cells of myelodysplastic syndromes].
    Huang HM; Xu RR; Ding RS; Lu DY; Liu H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Oct; 12(5):610-4. PubMed ID: 15498120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.
    Liu Z; Yang L; Cui Y; Wang X; Guo C; Huang Z; Kan Q; Liu Z; Liu Y
    Inflamm Bowel Dis; 2009 Aug; 15(8):1133-44. PubMed ID: 19322899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes.
    Kitagawa M; Saito I; Kuwata T; Yoshida S; Yamaguchi S; Takahashi M; Tanizawa T; Kamiyama R; Hirokawa K
    Leukemia; 1997 Dec; 11(12):2049-54. PubMed ID: 9447819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deviation of type I and type II T cells and its negative effect on hematopoiesis in myelodysplastic syndrome.
    Wu L; Li X; Chang C; Ying S; He Q; Pu Q
    Int J Lab Hematol; 2008 Oct; 30(5):390-9. PubMed ID: 19046314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells.
    Laranjeira P; Pedrosa M; Pedreiro S; Gomes J; Martinho A; Antunes B; Ribeiro T; Santos F; Trindade H; Paiva A
    Stem Cell Res Ther; 2015 Jan; 6(1):3. PubMed ID: 25559824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
    Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
    Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes.
    Sawanobori M; Yamaguchi S; Hasegawa M; Inoue M; Suzuki K; Kamiyama R; Hirokawa K; Kitagawa M
    Leuk Res; 2003 Jul; 27(7):583-91. PubMed ID: 12681357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excessive production of tumor necrosis factor-alpha by bone marrow T lymphocytes is essential in causing bone marrow failure in patients with aplastic anemia.
    Hara T; Ando K; Tsurumi H; Moriwaki H
    Eur J Haematol; 2004 Jul; 73(1):10-6. PubMed ID: 15182332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of interleukin-12 on natural killer cell cytotoxicity and the production of interferon-gamma and tumour necrosis factor-alpha in patients with myelodysplastic syndromes.
    Ogata K; Tamura H; Yokose N; An E; Dan K; Hamaguchi H; Sakamaki H; Onozawa Y; Clark SC; Nomura T
    Br J Haematol; 1995 May; 90(1):15-21. PubMed ID: 7786778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-17-producing CD4(+) T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome.
    Kordasti SY; Afzali B; Lim Z; Ingram W; Hayden J; Barber L; Matthews K; Chelliah R; Guinn B; Lombardi G; Farzaneh F; Mufti GJ
    Br J Haematol; 2009 Apr; 145(1):64-72. PubMed ID: 19210506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine expression patterns and mesenchymal stem cell karyotypes from the bone marrow microenvironment of patients with myelodysplastic syndromes.
    Xiong H; Yang XY; Han J; Wang Q; Zou ZL
    Braz J Med Biol Res; 2015 Mar; 48(3):207-13. PubMed ID: 25608238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon gamma and tumour necrosis factor alpha are overexpressed in bone marrow T lymphocytes from paediatric patients with aplastic anaemia.
    Dufour C; Corcione A; Svahn J; Haupt R; Battilana N; Pistoia V
    Br J Haematol; 2001 Dec; 115(4):1023-31. PubMed ID: 11843845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human β-defensin-2 enhances IFN-γ and IL-10 production and suppresses IL-17 production in T cells.
    Kanda N; Kamata M; Tada Y; Ishikawa T; Sato S; Watanabe S
    J Leukoc Biol; 2011 Jun; 89(6):935-44. PubMed ID: 21367976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.
    Strengell M; Lehtonen A; Matikainen S; Julkunen I
    J Leukoc Biol; 2006 Jun; 79(6):1279-85. PubMed ID: 16551679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro deprivation of CD8(+)CD57(+)T cells promotes the malignant growth of bone marrow colony cells in patients with lower-risk myelodysplastic syndrome.
    Zheng Z; Qianqiao Z; Qi H; Feng X; Chunkang C; Xiao L
    Exp Hematol; 2010 Aug; 38(8):677-84. PubMed ID: 20394797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha.
    Albanesi C; Cavani A; Girolomoni G
    J Immunol; 1999 Jan; 162(1):494-502. PubMed ID: 9886425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.